• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

New publication from TTM1 - Serum Tau

09 November 2017

Published in this month's Annals of Neurology, Niklas Mattsson and colleagues measured the neuronal protein tau as a predictor of neurological outcome after cardiac arrest. Results seem to indicate that Tau improves outcome prediction compared to NSE, which is the currently recommended by guidelines. There was no difference in serum tau levels between patients managed at 33°C or 36°C. We are looking forward to validating these results in TTM2. 

Find the article here: http://bit.ly/2jdrKV6

 

News

TTM2 Trial Results Meeting

08 June 2021

Protocol for the TTM2 follow-up published in Resuscitaiton

15 April 2020

Covid-19 update

20 March 2020

Randomisation Complete!

20 January 2020

TTM2 - Trial design article (open access).

16 November 2019

Formal Interim analysis

04 October 2019

1000!

29 May 2019

Investigator meeting in Lund 22 May

22 May 2019

Largest cardiac arrest trial in an ICU setting

22 May 2019

New FAQs

04 February 2019

Pages

  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org